Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-027024
Filing Date
2014-04-10
Accepted
2014-04-10 17:45:13
Documents
1
Period of Report
2014-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7182
  Complete submission text file 0001209191-14-027024.txt   9877
Mailing Address 435 TASSO STREET SUITE 305 PALO ALTO CA 94301
Business Address 435 TASSO STREET SUITE 305 PALO ALTO CA 94301 650-543-1555
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-A LP (Reporting) CIK: 0001428991 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 14758209

Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 281-528-1958
ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP (Reporting) CIK: 0001428992 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 14758210

Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 281-364-1555
ESSEX WOODLANDS HEALTH VENTURES FUND VIII-B LP (Reporting) CIK: 0001452935 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 14758208

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations